483
BSP Pharmaceuticals SpAFDA 483 - BSP Pharmaceuticals SpA - March 23, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of BSP Pharmaceuticals S.p.A., a drug product manufacturer, revealed significant deficiencies in manufacturing process controls, complaint handling, equipment qualification, and electronic data integrity. The firm failed to establish adequate control procedures for media fills, properly investigate customer complaints, qualify equipment for its intended use, and ensure the accuracy and control of electronic data from computerized systems.
Open in Dashboard
ID · 3c1888ce-6dae-4af7-9cc7-89243028fb7e